Quantum Diamond Technologies

QDTI operates in the healthcare diagnostics market, providing a cutting-edge magnetic-based immunoassay detection platform. This technology addresses the limitations of traditional optical detection methods, such as lengthy result times, extensive sample washing, and high costs. QDTI's platform uses magnetic tags to offer a more reliable, flexible, and cost-effective solution for identifying biomarkers, which are indicators of various diseases. The company serves a diverse range of clients, including hospitals, research and development labs, pharmaceutical companies, government agencies, and independent labs. QDTI's business model revolves around selling its diagnostic instruments and offering assay development and partnership opportunities. Revenue is generated through the sale of these instruments, as well as through collaborations and partnerships. The platform is particularly impactful in critical healthcare areas such as neurology, cardiovascular diseases, immuno-oncology, and infectious diseases. By leveraging quantum mechanics, QDTI aims to revolutionize the diagnostics landscape, making it faster, more precise, and more accessible. Keywords: magnetic-based diagnostics, biomarkers, healthcare, immunoassay, quantum mechanics, neurology, cardiovascular, immuno-oncology, infectious diseases, cost-effective.